Home > Annual Financials > IPCA LABORATORIES

IPCA LABORATORIES Financial Statement Analysis
[BOM: 524494|NSE : IPCALAB]

The Revenues of IPCA LABORATORIES have increased by 16.11% YoY .
The Earnings Per Share (EPS) of IPCA LABORATORIES has increased by 54.68 % YoY.
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Annual Financial Results
[BOM: 524494|NSE : IPCALAB]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹8,897 Cr₹7,662 Cr₹6,204 Cr₹5,797 Cr₹5,395 Cr
Expenses ₹7,226 Cr₹6,398 Cr₹5,301 Cr₹4,539 Cr₹3,914 Cr
Operating Profit (Excl OI) ₹1,671 Cr₹1,264 Cr₹903 Cr₹1,258 Cr₹1,481 Cr
Other Income ₹151 Cr₹184 Cr₹152 Cr₹122 Cr₹129 Cr
Interest ₹88 Cr₹141 Cr₹48 Cr₹11 Cr₹12 Cr
Depreciation ₹398 Cr₹357 Cr₹262 Cr₹232 Cr₹209 Cr
Profit Before Tax ₹1,131 Cr₹843 Cr₹745 Cr₹1,136 Cr₹1,389 Cr
Profit After Tax ₹788 Cr₹529 Cr₹492 Cr₹911 Cr₹1,149 Cr
Consolidated Net Profit ₹738 Cr₹547 Cr₹471 Cr₹884 Cr₹1,140 Cr
Earnings Per Share (Rs)₹44.98₹29.08₹21.57₹18.58₹34.85
PAT Margin (%)12.358.816.877.8815.63
ROE(%)15.8811.868.708.7017.92
ROCE(%)19.4115.2713.1011.7120.46
Total Debt/Equity(x)0.090.190.220.250.14

Key Financials

Market Cap : ₹ 47,181.9 Cr
Revenue (TTM) : ₹ 10,479.0 Cr
Net Profit(TTM) : ₹ 1,487.8 Cr
EPS (TTM) : ₹ 58.6
P/E (TTM) : 31.7

Industry Peers & Returns1W1M1Y
IPCA LABORATORIES -1.4% -3% 24.1%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 9.1% 6.6%
DIVIS LABORATORIES -2.7% 22.2% 70%
TORRENT PHARMACEUTICALS -1% 2% 20.8%
CIPLA 1.7% 7.8% -7.3%
DR REDDYS LABORATORIES 1.5% 13% 12.1%
MANKIND PHARMA -0.9% 15.3% 16.5%
LUPIN 1% 2.2% -4.2%
ZYDUS LIFESCIENCES 0.8% 7.4% 26.6%


IPCA LABORATORIES Revenues
[BOM: 524494|NSE : IPCALAB]

Y-o-Y

16.11 %

5 Yr CAGR

13.32 %

Years Revenues % Change
Mar2026 ₹8,897 Cr
16.11
Mar2025 ₹7,662 Cr
23.50
Mar2024 ₹6,204 Cr
7.03
Mar2023 ₹5,797 Cr
7.45
Mar2022 ₹5,395 Cr -


IPCA LABORATORIES Operating Profit
[BOM: 524494|NSE : IPCALAB]

Y-o-Y

32.16 %

5 Yr CAGR

3.05 %

Years Operating Profit % Change
Mar2026 ₹1,671 Cr
32.16
Mar2025 ₹1,264 Cr
39.94
Mar2024 ₹903 Cr
-28.18
Mar2023 ₹1,258 Cr
-15.10
Mar2022 ₹1,481 Cr -

Operating Margins
Y-o-Y

13.82 %

5 Yr CAGR

-9.06 %

Years Operating Margin% % Change
Mar2026 18.78%
13.82
Mar2025 16.5%
13.32
Mar2024 14.56%
-32.90
Mar2023 21.7%
-20.98
Mar2022 27.46% -

IPCA LABORATORIES Profit After Tax
[BOM: 524494|NSE : IPCALAB]

Y-o-Y

34.77 %

5 Yr CAGR

-10.31 %

Years Profit After Tax % Change
Mar2026 ₹738 Cr
34.77
Mar2025 ₹547 Cr
16.13
Mar2024 ₹471 Cr
-46.69
Mar2023 ₹884 Cr
-22.45
Mar2022 ₹1,140 Cr -

PAT Margins
Y-o-Y

40.18 %

5 Yr CAGR

-5.72 %

Years PAT Margin(%) % Change
Mar2026 12.35 %
40.18
Mar2025 8.81 %
28.24
Mar2024 6.87 %
-12.82
Mar2023 7.88 %
-49.58
Mar2022 15.63 % -

IPCA LABORATORIES Earnings Per Share (EPS)
[BOM: 524494|NSE : IPCALAB]

Y-o-Y

54.68 %

5 Yr CAGR

6.59 %

Years EPS % Change
Mar2026 ₹45
54.68
Mar2025 ₹29
34.82
Mar2024 ₹22
16.09
Mar2023 ₹19
-46.69
Mar2022 ₹35 -

IPCA LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524494|NSE : IPCALAB]

Y-o-Y

27.11 %

5 Yr CAGR

-1.31 %

Years ROCE % Change
Mar2026 19.41%
27.11
Mar2025 15.27%
16.56
Mar2024 13.1%
11.87
Mar2023 11.71%
-42.77
Mar2022 20.46% -

IPCA LABORATORIES Share Price vs Sensex

Current Share Price : ₹1,859.8
Current MarketCap: ₹ 47,181.9 Cr
Updated EOD on :Nov 19,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-1.4%

-3%

24.1%

SENSEX

1.4%

12.4%

-1.7%

IPCA LABORATORIES related INDICES

BSE Indices1W1M1Y
BSE 250 LARGEMIDCAP INDEX 0.5% 9.4% 0%
BSE 500 0.3% 8.6% 0.2%
BSE 1000 0.2% 8% 0.7%
BSE HEALTHCARE -0.2% 10.8% 18.8%
BSE 150 MIDCAP INDEX -0.7% 5.2% 0.9%
NSE Indices1W1M1Y
NIFTY MIDSMALL INDIA CONSUMPTION 0.8% 7.7% -4.5%
NIFTY HEALTHCARE INDEX 0.2% 11.5% 17.1%
NIFTY 500 0.1% 8.4% 0.3%
NIFTY TOTAL MARKET 0% 8.1% 0.7%
NIFTY500 HEALTHCARE INDEX 0% 11.6% 18.9%

You may also like the below Video Courses


FAQ about IPCA LABORATORIES Financials


How the annual revenues of IPCA LABORATORIES have changed ?

The Revenues of IPCA LABORATORIES have increased by 16.11% YoY .

How the Earnings per Share (EPS) of IPCA LABORATORIES have changed?

The Earnings Per Share (EPS) of IPCA LABORATORIES has increased by 54.68 % YoY .